Search
cefprozil (Cefzil)
Tradename: Cefzil. 2nd generation cephalosporin.
Indications:
- treatment of bacterial infections due to susceptible organisms
- acute otitis media
- upper respiratory tract infections
- tonsillitis
- bronchitis
- skin or soft tissue infection
- empiric treatment of fever of unknown origin
Dosage: 250-500 mg PO QD or divided BID.
Tabs: 250, 500 mg, Suspension: 125, 250 mg/5 mL.
Antimicrobial activity:
Gram positive
- Streptococcus
- Streptococcus group A
- Streptococcus group B
- Streptococcus group C
- Streptococcus group G
- Streptococcus pneumonia
- Staphylococcus aureus (MSSA)
- Staphylococcus epidermidis (+/-)
Gram negative
- Neisseria gonorrhoeae
- Neisseria meningitidis
- Moraxella catarrhalis
- Haemophilus influenzae
- Escherichia coli
- Klebsiella species
- Salmonella species
- Shigella species
- Proteus mirabilis
Anaerobes
- Bacteroides melaninogenicus
- Clostridium species
- Peptostreptococcus species
Interactions
drug interactions
drug adverse effects of cephalosporins
General
cephalosporin, 2nd generation
Properties
MISC-INFO: elimination route KIDNEY
pregnancy-category B
safety in lactation ?
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Deprecated Reference